Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
RFK Jr. pledges to keep the US at the center of the biotech 'revolution'
12 hours ago
Pharma
Former FDA scientist and psychedelics researcher hired as CDER deputy director
12 hours ago
People
FDA+
RFK Jr. says he did not commit to upholding ACIP roster to secure Cassidy’s backing
12 hours ago
Pharma
FDA+
Novo and Hims' crossed wires
12 hours ago
Health Tech
Exclusive: Mikael Dolsten joins gene editing startup's board and eyes 'opportunities' with new FDA leaders
13 hours ago
People
Startups
Exclusive: FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say
13 hours ago
FDA+
Revolution inks up to $2B 'flexible' funding deal to advance RAS inhibitor pipeline
16 hours ago
Financing
Deals
Nektar's mid-stage eczema data deliver key win in bid for company turnaround
16 hours ago
R&D
ArriVent plots next steps for lung cancer drug; Neuron23's $96.5M raise
16 hours ago
News Briefing
UK government blueprints ambition to be a key life sciences hub
20 hours ago
R&D
Pharma
Nuvalent closes in on FDA filing for lung cancer drug with topline Phase 1/2 data
20 hours ago
R&D
The politics of vaccination take center stage as RFK Jr.’s rebuilt CDC panel is set to meet
Yesterday
FDA+
Updated: Amgen plans lower, slower MariTide doses for obesity drug’s Phase 3
Yesterday
R&D
AstraZeneca, Daiichi Sankyo gain lung cancer indication for Enhertu successor
Yesterday
Pharma
FDA+
Roche plans to pit next-gen hemophilia A antibody against Hemlibra in Phase 3
Yesterday
R&D
Supreme Court asks DOJ to weigh in on Hikma ‘skinny label’ fight against Amarin
Yesterday
Pharma
Law
Exelixis' positive Phase 3 colorectal cancer data boost stock
Yesterday
R&D
Novo ends short-lived partnership with Hims over compounded obesity drugs
Yesterday
Startups
Pharma
Formation Bio’s up to €545M licensing deal with Sanofi; Otsuka, Harbour BioMed team up
Yesterday
News Briefing
Cidara nearly doubles in value as antiviral biologic prevents flu in mid-stage trial
Yesterday
R&D
Acting CDER chief is leaving after almost nine years at FDA
Yesterday
People
FDA+
Lilly’s bimagrumab boosts weight and fat loss when added to Novo's Wegovy
Yesterday
R&D
Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics
Yesterday
Deals
Diagnostics
Updated: Compass claims Phase 3 win in depression for psilocybin drug, yet stock plummets
Yesterday
R&D
1
2
3
4
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit